Dorzopt Plus, eye drops 20 mg/ml+5 mg/ml 5 ml

Antiglaucoma drug contains two active components: timolol and dorzolamide, each of which reduces increased intraocular pressure by reducing the secretion of intraocular fluid.

Indications

Increased intraocular pressure with:
pseudoexfoliative glaucoma.
open-angle glaucoma;

Pharmacological effect

An antiglaucoma drug that contains two active components: timolol and dorzolamide, each of which reduces increased intraocular pressure by reducing the secretion of intraocular fluid.

Special instructions

During the treatment period, it is necessary to refrain from driving vehicles and engaging in potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Active ingredient

Dorzolamide, Timolol

Composition

1 ml of solution contains:

Pregnancy

The drug Dorzopt Plus is contraindicated for use during lactation (breastfeeding) and pregnancy.

Contraindications

Hypersensitivity to the components of the drug;

Side Effects

Timolol

Interaction

No studies have been conducted on the interaction of Dorzopt Plus with other drugs. However, there is a possibility of enhancing the hypotensive effect and/or developing severe bradycardia with the combined use of timolol ophthalmic solution and slow calcium channel blockers, sympatholytics, beta-blockers, antiarrhythmics (including amiodarone), cardiac glycosides, parasympathomimetics, opioid analgesics and MAO inhibitors.

Overdose

Symptoms: unintentional overdose of timolol in the form of eye drops with the development of systemic effects of an overdose of beta-blockers for systemic use – dizziness, shortness of breath, cardiac arrest, bradycardia, headache, bronchospasm.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C

Shelf life

2 years

Manufacturer

K.O.Rompharm Company S.R.L., Romania